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Abstract 
Background: Since 2005, Ethiopia has aggressively scaled up malaria prevention and case management. As a result, 
the number of malaria cases and deaths has significantly declined. In order to track progress towards the elimina-
tion of malaria in Amhara Region, coverage of malaria control tools and current malaria transmission need to be 
documented.
Methods: A cross-sectional household survey oversampling children under 5 years of age was conducted during 
the dry season in 2013. A bivalent rapid diagnostic test (RDT) detecting both Plasmodium falciparum and Plasmodium 
vivax and serology assays using merozoite antigens from both these species were used to assess the prevalence of 
malaria infections and exposure to malaria parasites in 16 woredas (districts) in Amhara Region.
Results: 7878 participants were included, with a mean age of 16.8 years (range 0.5–102.8 years) and 42.0% being 
children under 5 years of age. The age-adjusted RDT-positivity for P. falciparum and P. vivax infection was 1.5 and 
0.4%, respectively, of which 0.05% presented as co-infections. Overall age-adjusted seroprevalence was 30.0% for P. 
falciparum, 21.8% for P. vivax, and seroprevalence for any malaria species was 39.4%. The prevalence of RDT-positive 
infections varied by woreda, ranging from 0.0 to 8.3% and by altitude with rates of 3.2, 0.7, and 0.4% at under 2000, 
2000–2500, and >2500 m, respectively. Serological analysis showed heterogeneity in transmission intensity by area 
and altitude and evidence for a change in the force of infection in the mid-2000s.
Conclusions: Current and historic malaria transmission across Amhara Region show substantial variation by age 
and altitude with some settings showing very low or near-zero transmission. Plasmodium vivax infections appear to 
be lower but relatively more stable across geography and altitude, while P. falciparum is the dominant infection in 
the higher transmission, low-altitude areas. Age-dependent seroprevalence analyses indicates a drop in transmission 
occurred in the mid-2000s, coinciding with malaria control scale-up efforts. As malaria parasitaemia rates get very low 
with elimination efforts, serological evaluation may help track progress to elimination.
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Background
Malaria is a major public health challenge in Ethiopia, 
accounting for approximately 12 million cases each year 
[1]. Malaria epidemiology in Ethiopia is relatively unique 
in Africa in that both Plasmodium falciparum and Plas-
modium vivax are present and malaria transmission is 
generally unstable, with focal, seasonal outbreaks and 
occasional epidemics [1].
During the last decade, significant scale-up of inter-
ventions—including population-wide distribution of 
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free, long-lasting insecticide-treated nets (LLINs), 
indoor residual spraying (IRS), nationwide roll-out of 
rapid diagnostic tests (RDTs) and artemisinin-based 
combination treatments—to reduce malaria transmis-
sion was implemented throughout the country [2]. 
This resulted in a significant reduction in the preva-
lence of the malarial infection and illness and its con-
sequences [3–6]. It is estimated that, if these activities 
are continued and sustained in the coming 5 years, 50 
million malaria cases will be averted and $39 million in 
costs associated with patient care and treatment will 
be saved [7]. It is in this context that there is a renewed 
commitment to advance toward malaria elimination in 
Ethiopia.
To facilitate malaria elimination in geographical areas 
with historically low transmission [8], it is imperative to 
first document the current levels of malaria transmission 
and to provide the necessary evidence to extend effec-
tive malaria elimination activities. Measuring malaria 
transmission in low transmission areas is challenging, 
as microscopy and/or RDT results both underestimate 
infections and typically present a narrow dynamic range 
of malaria prevalence estimates, which require large sam-
ple sizes [9–11]. While molecular diagnostic tests such as 
PCR are more sensitive and may capture a more accurate 
representation of infection prevalence, they are currently 
impractical in terms of complexity and cost, and in the 
case of P. vivax, require a larger specimen volume [12, 
13]. Serological markers measuring cumulative exposure 
can be a more practical and cost effective alternative, and 
may provide improved discrimination of transmission 
rates in the low to medium transmission areas by com-
paring seroprevalence and seroconversion rates. A recent 
study based on school surveys from the Oromia Regional 
State of Ethiopia, demonstrate the value of serological 
marker-based indicators in low transmission areas (sero-
prevalence of 0–12.7% for P. falciparum and 0–4.5% for P. 
vivax) [14].
A collaborative effort between the Federal Ministry 
of Health and Amhara National Regional State Health 
Bureau (ANRSHB); the Malaria Control and Elimination 
Partnership in Africa (MACEPA), a programme at PATH; 
and The Carter Center (TCC) was established to develop, 
implement, and evaluate a comprehensive malaria elimi-
nation strategy in selected areas of Amhara Region, Ethi-
opia. Before the implementation of activities, this study 
was conducted to estimate 2013 baseline rates of: (1) core 
malaria interventions including LLIN ownership and use, 
and IRS coverage; and (2) current and cumulative malaria 
infections due to P. falciparum and/or P. vivax using a 
population-based survey with malaria RDTs and malaria 
serology.
Methods
Study area
This study was conducted in Ethiopia’s Amhara Region, 
which has a population of approximately 20 million peo-
ple. In 2012, the reported annual incidence of malaria 
in the Amhara Region was 60 cases per 1000 popula-
tion, accounting for 19% of the national malaria burden 
[15, 16]. The Amhara Region has significant variations 
in altitude, temperature, and annual rainfall resulting in 
areas of differing malaria risk and transmission for both 
P. falciparum and P. vivax. Malaria transmission is sea-
sonal, with the major malaria transmission season being 
between September and December. For the purpose of 
this study, woredas (districts) of Amhara were divided 
into four eco-epidemiological zones (very low, very 
low to low, low, and low to moderate) based on weekly 
malaria incidence data from 2012. A total of 16 woredas 
from these four unique eco-epidemiological zones were 
selected (Fig. 1a, b).
Ethical considerations
This research protocol was reviewed and approved by 
ethical review committees at Amhara National Regional 
State (Amhara Research Ethics Review Committee), 
PATH, and Emory University.
Study design and data collection
A cross-sectional household survey was conducted in 
March–April 2013 during the dry, low-transmission 
season to provide estimates of malaria burden and cov-
erage of malaria control tools at woreda level in 16 tar-
get woredas. Woreda-stratified sampling was used to 
draw a sample from each woreda that was proportional 
to the woreda population. Within each woreda, enu-
meration areas (EAs) were selected with probability pro-
portional to size. A total of 278 EAs were selected from 
woreda listings of all EAs developed by the Central Sta-
tistical Agency for the 2007 census. In each selected EA, 
25 households were selected using simple random sam-
pling from a sampling frame of all households created by 
EA mapping. EAs were mapped using personal digital 
assistants (PDAs). Within each sampled household, all 
children aged 6 months to 4 years old were eligible for 
malaria testing. Household members over 5 years of age 
were eligible in one out of every four households. Indi-
viduals were invited to participate and were included 
after verbal informed consent was obtained.
A standardized questionnaire to collect information on 
socio-demographic characteristics, knowledge and atti-
tudes about malaria, and use of malaria control tools was 
administered to each participant. Data were collected 
using PDAs. Finger-prick blood samples were collected 
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Fig. 1 a Amhara Region, Ethiopia, b survey areas (woredas) selected for the Malaria Elimination, colour-coded light to dark from lowest to highest 
for altitude, c Plasmodium falciparum RDT prevalence, d Plasmodium vivax RDT prevalence, e Plasmodium falciparum seroprevalence, and f Plasmo-
dium vivax seroprevalence
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from consenting participants to perform an RDT (biva-
lent SD Bioline Malaria Ag P.f./P.v. HRP-2/pLDH POCT) 
and prepare dried blood spots (DBS) on filter paper. Par-
ticipants with a positive RDT result received antima-
larial treatment per national guidelines. Those seriously 
ill were referred to seek immediate care at the nearest 
health facility.
Laboratory methods
Samples were assayed for anti-malarial IgG antibody 
responses to P. falciparum and P. vivax merozoite sur-
face protein (MSP-119) and apical membrane antigen 1 
(AMA-1) recombinant protein [11] by enzyme-linked 
immunosorbent assay (ELISA) at the Amhara Region 
Health Research Laboratory Centre. Three-millimetre 
diameter circles were punched from DBS and recon-
stituted in PBS buffer as previously described [10, 17]. 
Plates were coated with antigens at a concentration of 
0.5  μg/mL overnight. Eluates from test samples were 
added at a dilution of 1:1000 and species-specific positive 
controls sera were added at serial dilutions on each plate 
to generate standard curves. After overnight incubation, 
horseradish-peroxidase-conjugated rabbit-anti-human 
IgG (DAKO, USA) secondary antibody was added fol-
lowed by substrate Tetramethylbenzidine (TMB) (Sur-
Modics, USA) as color detection. Optical density (OD) 
values were read at 450 nm after 15 min incubation with 
the substrate.
Data analysis
Data analysis was done using Stata (College Station, 
USA). Estimates of seroprevalence and prevalence of 
malaria infection by RDT were weighted to account for 
the sampling design.
Serology samples with duplicate OD values that var-
ied by more than 50% were excluded from the analysis. 
Duplicate OD results were averaged, the raw ODs were 
transformed into titres using the standard curve gener-
ated by the positive control on each assay plate. Seroposi-
tivity was calculated by fitting a Gaussian distribution 
to normalized OD values using maximum-likelihood 
methods assuming two distributions, a narrow seron-
egative, and broad seropositive [18]. For each antigen, 
the cutoff value was determined by the mean OD of the 
seronegative population plus three standard deviations 
[11]. Plasmodium falciparum and P. vivax seropositivity 
was defined as an individual being positive for either or 
both respective antigens, and was analysed by age, alti-
tude, and woreda. Simple reverse catalytic models were 
fitted to seroprevalence and age data using maximum 
likelihood methods and seroconversion rates (SCR) were 
estimated [11]. Evidence for models with two forces of 
infection were investigated using profile likelihood plots 
and compared with a model with a single force of infec-
tion using log-likelihood tests [10].
Logistic regression was employed to determine the 
likelihood of being RDT-positive for P. vivax and/or P. 
falciparum (odds ratios [OR]; 95% confidence inter-
vals [CI]) as compared to having a negative RDT test 
result, for sex, age, altitude, fever, malaria history, bed 
net ownership, bed net use, and IRS spraying in the last 
12  months. Univariate and multivariate models includ-
ing all variables to estimate adjusted ORs were run. 
Two independent models were run for altitude (<2000 
and  ≥2000  m) because there was a significant effect 
modification between altitude and bed net use/owner-
ship and altitude and IRS. Moreover, the national malaria 
programme uses the 2000 m altitude cut-off for targeted 
deployment of malaria control tools, hence supporting 
the a priori plan to run the two models separately. Also, 
it was not possible to add a third altitude band above 
2500  m for the regression as was done for the descrip-
tive analysis because the number of RDT positives was 
too small. Similar regression models were employed for P. 
falciparum and P. vivax seropositivity.
Results
Study population
A total of 7878 individuals from 16 woredas (Fig. 1a, b) 
participated in the cross-sectional survey and had ques-
tionnaire data, RDT malaria blood testing results, and 
serology results available for analysis. 52.1% of partici-
pants were female, 42.0% were less than 4 years of age, 
and 55.1% lived below 2000  m (Table  1). At the house-
hold level, 59.2% owned a bed net and 31.4% had received 
IRS in the previous 12  months. Only 21.7% of partici-
pants reported having used a bed net the previous night, 
and 11.6% reported having had a fever in the previous 
2 weeks. A total of 151 (1.9%) were RDT-positive (age-
adjusted prevalence) (Table  2); 120 (1.5%) were RDT-
positive for P. falciparum, 35 (0.4%) for P. vivax, and 
4 (0.05%) for both P. falciparum and P. vivax. Among 
RDT-positive individuals, 41.0% were asymptomatic (no 
reported fever in the last 2 weeks), with no significant 
differences by age group. The overall seroprevalence was 
39.4% (n = 3102), with 30.0% (2367) being P. falciparum 
seropositive and 21.8% (1720) P. vivax seropositive.
Geospatial distribution of RDT‑positivity 
and seroprevalence
There was substantial variation in RDT-positivity for P. 
falciparum (from <1.0% to roughly 8.0%) (Fig. 1c) and less 
variation for P. vivax (from 0% to roughly 1.5%) (Fig. 1d) 
over the 16 woredas. Plasmodium falciparum seropreva-
lence by woreda ranged from 61.5% in Metema to 4.8% 
in Tehuledere (Fig.  1e); and P. vivax seroprevalence by 
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woreda ranged from 43.7% in Bahir Dar Zuriya to 3.7% 
in Aneded (Fig. 1f ). Overall, the RDT-positivity rates and 
the seroprevalence for both P. falciparum and P. vivax 
decreased with increasing altitude (Fig. 2). While higher 
RDT and serology prevalence was observed in woredas 
located at lower altitudes, there was heterogeneity within 
the different elevation strata (Fig. 2). The RDT-positivity 
by altitude was 3.2, 0.7, and 0.4% for <2000, 2000–2500, 
and  >2500  m, respectively. Respective RDT-positivity 
for P. falciparum and P. vivax at these altitudes were 2.7 
and 0.5% (<2000 m), 0.3 and 0.4% (2000–2500 m), and 0 
and 0.4% (≥2500  m) (Fig.  3a). Additionally, the respec-
tive seroprevalence for P. falciparum and P. vivax at these 
altitudes were 41.6 and 28.8% (<2000 m), 19.8 and 18.9% 
(2000–2500 m), and 10.7 and 10.6% (≥2500 m) (Fig. 3a). 
There were no significant differences in seroprevalence 
by gender across the different elevation strata.
RDT‑positivity and seropositivity by age
During this low transmission season, RDT-positivity for 
both P. falciparum and P. vivax was highest amongst 
0–9-year-olds, after which RDT-positivity decreased 
with increasing age (Fig.  3b). Across all age groups, P. 
falciparum RDT-positivity was higher than P. vivax 
RDT-positivity.
Plasmodium falciparum and P. vivax seroprevalence 
increased by age group, although a slight decrease among 
those aged 60  years and older was observed (Fig.  3b). 
This general pattern of increasing P. falciparum and P. 
vivax seroprevalence by age was seen in each of the alti-
tude strata (Fig. 4). Overall, P. falciparum seroprevalence 
was higher than P. vivax seroprevalence across all age 
groups. However, when stratified by altitude, this pattern 
was only observed for those living at <2000 m. Plasmo-
dium falciparum and P. vivax seroprevalences were more 
similar at higher altitudes, although there was variability 
observed in the >2500 m stratum, which is likely due to 
small number of positives per age group.
Seroconversion rates
The age seroconversion plots for antibody responses for 
P. falciparum and P. vivax are shown in Fig. 5. The model 
Table 1 Characteristics of survey participants (n = 7878)
Unweighted estimates
Number Percent (%)
Sex
 Female 4101 52.1
 Male 3777 47.9
Age (years)
 6 months–4 3307 42.0
 5–9 924 11.7
 10–19 1094 13.9
 20–39 1486 18.9
 40–59 696 8.8
 60+ 371 4.7
Woreda
 Very low transmission
  Aneded 250 3.2
  Awabel 391 5.0
  Gozamin 393 5.0
  Shebel Berenta 315 4.0
Very low to low transmission
 Bati 396 5.0
 Dawa Chef 589 7.5
 Kalu 631 8.0
 Tehuledere 275 3.5
Low transmission
 Bahir Dar Zuriya 771 9.8
 Dera 830 10.5
 Fogera 900 11.4
 Mecha 1249 15.9
Low to moderate transmission
 Genda Wuha Town 53 0.7
 Gulegu 78 1.0
 Metema 424 5.4
 Quara 333 4.2
Altitude (m)
 <2000 4388 55.1
 2000–2500 3175 40.3
 >2500 365 4.6
Bed net use the previous night
 No 6165 78.3
 Yes 1713 21.7
Fever in last 2 weeks
 No 6951 88.4
 Yes 909 11.6
Table 2 Prevalence of  malaria infection by  RDT-positivity 
and seroprevalence (n = 7878)
Weighted estimates based on sampling strategy
Number Percent (%)
RDT-positivity
 P. falciparum 120 1.5
 P. vivax 35 0.4
 P. falciparum and P. vivax co-infection 4 0.05
 Total P. falciparum and/or P. vivax 151 1.9
Seroprevalence
 P. falciparum 2367 30.0
 P. vivax 1720 21.8
 P. falciparum and P. vivax co-infection 985 12.5
 Total P. falciparum and/or P. vivax 3102 39.4
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with two forces of infection (a higher force of infec-
tion prior to approximately 15  years ago and a lower 
force of infection in the last 15 years) provided a better 
fit to the data than a model with a single force of infec-
tion. These models suggest that a substantial reduc-
tion in the exposure to both P. falciparum and P. vivax 
infections has occurred within the last 10–15  years (P. 
falciparum: current SCR 0.032  year−1 [0.029–0.035], 
previous SCR 0.26  year−1 [0.11–0.57]; P. vivax: current 
SCR 0.034 year−1 [0.03–0.038], previous SCR 0.22 year−1 
[0.053–0.91]). The age seroconversion plots for antibody 
responses for P. falciparum and P. vivax by altitude strata 
are shown in Additional file 1, showing similar trends in 
all altitudes.
The prevalence of RDT-positivity, reported fever 
and seroprevalence decreased with increasing altitude 
(Additional file  2). Malaria risk factors associated with 
RDT-positivity and seroprevalence by altitude (<2000 
and ≥2000 m) are shown in Additional files 3 and 4. In 
both models, individuals with a reported fever in the past 
2 weeks were significantly more likely to be RDT-posi-
tive, and there was a decreasing risk of RDT-positivity 
with increasing age. In altitudes below 2000  m, house-
hold ownership of a bed net was significantly protective 
against RDT-positivity; in altitudes ≥2000 m, those with 
a recent history of malaria were significantly more likely 
to be RDT-positive, and households that received IRS in 
the last 12  months were significantly protected against 
RDT-positivity. For seroprevalence, in altitudes under 
2000  m, individuals with reported fever in the previous 
2 weeks were significantly more likely to be seropositive, 
and household ownership of a bed net was significantly 
protective of seropositivity. In altitudes  ≥2000  m, indi-
viduals with a history of malaria and households that had 
received IRS in the previous 12 months were significantly 
more likely to be seropositive.
Additional file  5 shows that seropositivity for P. falci-
parum is present in younger children across the different 
elevation strata, and persists even at the highest altitudes 
(>2500  m). However, all seropositive cases seen above 
2500 m are borderline positive, as they are near the limit 
of detection of 0.02 OD units.
Discussion
The overall RDT-positivity in the study area during the 
dry season (March–April) was 1.9%, when the preva-
lence of infection is expected to be significantly lower 
than during the major malaria transmission season, 
which is between September and December in Amhara 
region. This low prevalence of parasitaemia is probably 
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Fig. 2 Plasmodium falciparum and P. vivax RDT-positivity and seroprevalence by woreda. The woredas are arranged from highest to lowest altitude
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an underestimate due to the imperfect RDT sensitivity, 
however it confirms that ongoing transmission persists 
in this region at a low level into the dry/low transmission 
season. Another study conducted in July 2013 at the 
end of the dry season found a high prevalence (12.0%) 
of RDT-diagnosed Plasmodium infection in nearby 
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Fig. 3 Plasmodium falciparum and P. vivax RDT-positivity and seroprevalence by a altitude and b age group
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low-land farming areas of Amhara [19]. The use of small-
scale irrigation schemes employed to ensure food secu-
rity in the area during the dry season might contribute to 
maintaining the transmission. A recent study found that 
malaria transmission was significantly higher in irrigated 
areas and that was primarily due to the higher number of 
mosquito breeding sites such as waterlogged agricultural 
field puddles, leakage pools from irrigation canals and 
poorly functioning irrigation canals [20]. The relatively 
low use of malaria prevention tools (e.g., 59.2% house-
hold bed net ownership and 22% of individuals sleep-
ing under a bed net the previous night) might represent 
the specific targeting of LLINs to areas <2000 m and the 
study sample included many living at higher elevations 
(areas not targeted for LLINs). However, the relatively 
low use despite ownership highlights the continuous 
need to educate and increase the awareness that malaria 
persists year round, and therefore the use of bed nets and 
other malaria prevention strategies should be reinforced 
throughout the year [21].
RDT-positivity was highest among children 0–9  years 
of age, although this pattern was only seen in the lowest 
altitude areas. The higher prevalence of infection in this 
young age group is likely to be driven by lower levels of 
naturally acquired immunity, with higher parasitaemia 
densities and potentially longer persistence of parasitae-
mia at a level that could be detected by RDTs [22]. This 
shows that, even in low transmission areas like this one in 
Ethiopia, an age pattern reflecting build-up of immunity 
is observed [23].
Seroprevalence reflects cumulative exposure to 
malaria, and, with the antigenic targets used in this study, 
is expected to fluctuate less between the different trans-
mission seasons. As expected, seroprevalence increased 
with age for both P. falciparum and P. vivax antigens, 
reflecting the cumulative exposure to these infections 
over time, given that, once acquired, antibody responses 
to MSP-119 and AMA-1 can persist for several years [24]. 
Thus, seroprevalence in the youngest age group, which 
ranged from 2.3 to 11.4%, was associated with altitude, 
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and supports the observation of ongoing transmission 
showed by the RDT results in the same age range. The 
slight decline in seroprevalence among individuals aged 
60  years and older may be due to waning of antibody 
titers with age, or perhaps reflect decreased exposure 
to malaria transmission associated with a reduction of 
farming activities and/or less travel.
The RDT-positivity and the seroprevalence for both P. 
falciparum and P. vivax decreased with increasing alti-
tude, which reflects the well-known phenomenon that 
transmission is generally higher at lower altitudes. In 
areas below 2000 m, RDT positivity for P. falciparum was 
higher than for P. vivax (2.7 and 0.5%, respectively). How-
ever, at altitudes over 2500 m the opposite was found: the 
RDT prevalence for P. vivax was 0.4 and 0% for P. falci-
parum, which may be related to the fact that P. vivax can 
have persistent liver stages and infection relapses and is 
also more tolerant of lower ambient temperatures [25]. 
Moreover, a recent meta-analysis suggests that the pro-
portion of submicroscopic P. vivax infections is higher 
than for P. falciparum particularly in low transmission 
intensity areas [26].
The 2011 Malaria Indicator Survey (MIS) found the 
same altitude pattern, with a 13-fold higher prevalence of 
malaria infection in areas under 2000 m, as compared to 
higher altitudes [1]. Of note, in the 2011 MIS, at altitudes 
above 2000 m, P. falciparum was not detected by micros-
copy and P. falciparum positivity by RDT was of 0.3%, 
showing the variation due to the different sensitivities of 
the tests used and highlighting the challenges of monitor-
ing transmission in very low transmission areas.
The dominance of P. falciparum RDT-positivity and 
seroprevalence in areas under 2000 m suggests that these 
areas are driving the transmission in the Amhara Region 
by exporting infections to the higher altitude areas. At 
elevations over 2000 m, RDT prevalence was almost zero, 
and P. falciparum and P. vivax seroprevalences, which 
were nearly equivalent, were much lower. All age groups 
showed seropositivity, although seropositive children in 
areas above 2500  m had very low antibody titers. This 
suggests that local transmission in higher altitude areas 
is very low and that exposure to infection is likely to be 
acquired elsewhere and imported as a result of the popu-
lation’s mobility and/or migrant labour workforce [27, 
28].
Finally, seroconversion rates showed a statistically 
significant change in the force of malaria infection, sug-
gesting that malaria transmission intensity was higher 
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Fig. 5 Age-seroconversion plots for antibody responses to Plasmodium falciparum antigens (left) and P. vivax antigens (right). Triangles represent 
deciles of observed data, solid lines represent the fit to the data of a reverse catalytic conversion model and broken blue lines provide the 95% confi-
dence interval for this fit
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and was reduced nearly tenfold (from approximately 
25% of individuals seroconverting per year previously 
to 3% currently) in the early-to-mid-2000s in Amhara. 
This finding probably reflects the success of the recent 
aggressive scale-up of malaria control activities in the 
area [7].
In a low transmission setting such as Amhara, the typi-
cal malaria age pattern, where younger individuals, espe-
cially children, have the highest risk of infections, is also 
observed. Although reported fever in the past 2 weeks 
was a significant predictor of RDT-positivity, 63.1 and 
46.4% of RDT-positive individuals in altitudes  <2000 
and  ≥2000  m, respectively, did not report a history of 
fever. This suggests that naturally acquired immunity is 
attained early in life [22]. Similar results were observed 
during a population-wide malaria testing and treatment 
intervention implemented in six villages in Amhara 
Region, Ethiopia [29].
Household bed net ownership was significantly pro-
tective against both RDT positivity and seropositivity at 
altitudes under 2000  m, but not at 2000  m and above, 
primarily because bed net distribution programmes were 
focused specifically in lower altitudes where malaria 
transmission is known to be higher. Above 2000 m, IRS 
in the past 12 months was protective against RDT posi-
tivity, but was a significant risk factor for seropositivity. 
This may be due to the fact that certain IRS targeting 
programmes were implemented in areas ≥2000 m based 
on previous malaria outbreaks, and therefore may have 
masked the true effect of IRS spraying.
Conclusions
As observed in other malarious areas [30–34], there 
was both RDT-positivity and seroprevalence heteroge-
neity across and within the different malaria transmis-
sion eco-epidemiological zones in Amhara, with overall 
higher rates for P. falciparum compared to P. vivax and 
substantially higher transmission in lower altitude areas. 
Progress made in Ethiopia during the last decade in 
decreasing malaria transmission should continue with 
effective interventions tailored to the socio-epidemio-
logical characteristics of the area. Given the apparent 
importance of population mobility in the parasite trans-
mission patterns, specific interventions targeting the 
source areas at lower elevations and the mobile popula-
tion would be warranted to eliminate transmission in the 
highest altitude areas. Serology offers an opportunity to 
monitor transmission in low and seasonal transmission 
areas. Measuring changes in the transmission of malaria 
will be crucial to monitor progress toward malaria elimi-
nation, and serological surveys may be a critical tool in 
addition to infection detection to describe changes in 
malaria transmission.
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